Literature DB >> 11147225

Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).

N Gökbuget1, D Hoelzer, R Arnold, A Böhme, C R Bartram, M Freund, A Ganser, M Kneba, W Langer, T Lipp, W D Ludwig, G Maschmeyer, H Rieder, E Thiel, A Weiss, D Messerer.   

Abstract

The German Multicenter Study Group for Adult Acute Lymphoblastic leukemia (GMALL) has conducted 5 consecutive trials with more than 3000 patients since 1981. This article provides an overview on aims, treatment concepts, and results of these studies. It includes brief summaries on the development of prognostic models within the GMALL group and on approaches for prophylaxis of CNS relapse, and it summarizes specific treatment concepts for mature B-lineage acute lymphocytic leukemia.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11147225     DOI： 10.1016/s0889-8588(05)70188-x

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  52 in total

1.  Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.

Authors:  Jonathan I Sive; Georgina Buck; Adele Fielding; Hillard M Lazarus; Mark R Litzow; Selina Luger; David I Marks; Andrew McMillan; Anthony V Moorman; Susan M Richards; Jacob M Rowe; Martin S Tallman; Anthony H Goldstone
Journal:  Br J Haematol       Date:  2012-03-13       Impact factor: 6.998

Review 2.  Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia.

Authors:  Hagop Kantarjian; Deborah Thomas; Alan S Wayne; Susan O'Brien
Journal:  J Clin Oncol       Date:  2012-08-13       Impact factor: 44.544

Review 3.  Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years.

Authors:  Hagop Kantarjian; Susan O'Brien; Jorge Cortes; William Wierda; Stefan Faderl; Guillermo Garcia-Manero; Jean-Pierre Issa; Elihu Estey; Michael Keating; Emil J Freireich
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

4.  Primary pancreatic Burkitt lymphoma presenting as acute pancreatitis.

Authors:  Francesco Carbonetti; Elsa Iannicelli; Margherita Federici; Andrea Bucciarelli; Emanuela Pilozzi; Esmeralda Conte; Vincenzo David
Journal:  J Gastrointest Cancer       Date:  2014-12

5.  Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.

Authors:  Hagop Kantarjian; Anthony Stein; Nicola Gökbuget; Adele K Fielding; Andre C Schuh; Josep-Maria Ribera; Andrew Wei; Hervé Dombret; Robin Foà; Renato Bassan; Önder Arslan; Miguel A Sanz; Julie Bergeron; Fatih Demirkan; Ewa Lech-Maranda; Alessandro Rambaldi; Xavier Thomas; Heinz-August Horst; Monika Brüggemann; Wolfram Klapper; Brent L Wood; Alex Fleishman; Dirk Nagorsen; Christopher Holland; Zachary Zimmerman; Max S Topp
Journal:  N Engl J Med       Date:  2017-03-02       Impact factor: 91.245

6.  Immunophenotypes and outcome of Philadelphia chromosome-positive and -negative Thai adult acute lymphoblastic leukemia.

Authors:  Chirayu Udomsakdi-Auewarakul; Orathai Promsuwicha; Chintana Tocharoentanaphol; Chanya Munhketvit; Kovit Pattanapanyasat; Surapol Issaragrisil
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

7.  A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia.

Authors:  Theis H Terwey; Philipp G Hemmati; Peter Martus; Ekkehart Dietz; Lam G Vuong; Gero Massenkeil; Bernd Dörken; Renate Arnold
Journal:  Haematologica       Date:  2009-12-08       Impact factor: 9.941

Review 8.  Novel therapeutic strategies in adult acute lymphoblastic leukemia--a focus on emerging monoclonal antibodies.

Authors:  Naval Daver; Susan O'Brien
Journal:  Curr Hematol Malig Rep       Date:  2013-06       Impact factor: 3.952

9.  Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia.

Authors:  Julie E Chang; Stephen C Medlin; Brad S Kahl; Walter L Longo; Eliot C Williams; Jack Lionberger; Kyungmann Kim; Jihoon Kim; Elizabeth Esterberg; Mark B Juckett
Journal:  Leuk Lymphoma       Date:  2008-12

10.  Phase I clinical and pharmacokinetic study of oral sapacitabine in patients with acute leukemia and myelodysplastic syndrome.

Authors:  Hagop Kantarjian; Guillermo Garcia-Manero; Susan O'Brien; Stefan Faderl; Farhad Ravandi; Robert Westwood; Simon R Green; Judy H Chiao; Patricia A Boone; Jorge Cortes; William Plunkett
Journal:  J Clin Oncol       Date:  2009-11-23       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.